-
Summary
Join our analysts to explore actionable market research strategies in the Unlocked Insights webinar series.
In this session, you will gain strategies for tracking market movements, monitoring key player, forecasting future activity, and building detailed financial estimates for deep industry insights. We’ll use the healthcare sector as a case study and examine developments in the TKI (tyrosine kinase inhibitors) drug pipeline market using AI-driven data solutions on S&P Capital IQ Pro and Visible Alpha.
Apply learnings so you can:
• Track market trends in real-time with our AI-powered research tools
• Utilize Visible Alpha’s product-level estimates for advanced financial modeling and market sizing
• Identify key players in the TKI pharma space and analyze firms’ market positioning and growth trajectory
• Discuss strategies for forecasting, outlook analysis and strategic decision-making
This session is tailored for professionals in healthcare, biotech, and those specializing in healthcare-related sectors within investment banking, private equity, and consulting, who need to stay informed on industry trends.
Speakers
S&P Global Market Intelligence
Ely Fal
S&P Global Market Intelligence
Associate Director of Market Development, Data & Research Solutions
Ely Fal is a market development associate in the desktop business development team based in London where his key focus areas are corporates and professional services in Europe. Throughout his time at S&P Global, Ely has worked with emerging start-ups and mature companies in private and public markets with scopes spanning Corporate Development, M&A, Strategy, Credit Risk, ESG and Business Development.
S&P Global Market Intelligence
Hamish Wells
S&P Global Market Intelligence
Commercial Team Lead, Visible Alpha
Hamish is a Representative in the Visible Alpha desktop and feed distribution team at S&P Market Intelligence with a specialisation in biopharma market data aimed Corporates and Buyside professionals. He joined S&P Global as part of the strategic acquisition of Visible Alpha in May 2024. During his time distributing Visible Alpha's quantitative broker forecast dataset, Hamish has worked with a broad range of clients including Corporate Investor Relations, Private Equity, Professional Services, and Hedge Funds professionals before specialising in working with Healthcare professionals and Analysts. Before Visible Alpha, Hamish worked as an Equity Research Analyst covering US Tech. Hamish received a BSc in Economics from the University of Manchester in 2018.
Questions?
Please contact us if you need more information or have trouble accessing the webinar.